CCA
ALNY icon

Column Capital Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Column Capital Advisors’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3
Closed -$1K – 716
2021
Q4 		$1K Buy
+3
New +$558 ﹤0.01% 690
2021
Q2 		– Sell
-100
Closed -$14K – 719
2021
Q1 		$14K Hold
100
– – ﹤0.01% 410
2020
Q4 		$13K Hold
100
– – ﹤0.01% 421
2020
Q3 		$15K Hold
100
– – ﹤0.01% 388
2020
Q2 		$14K Hold
100
– – ﹤0.01% 420
2020
Q1 		$11K Sell
100
-43
-30% -$4.96K ﹤0.01% 371
2019
Q4 		$16K Buy
+143
New +$14.3K 0.01% 395

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return